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In 2007, a joint Task Force of the American College of Cardiology, American Heart Association, European Society of Cardiology and the World Heart Federation published a redefinition of myocardial infarction (MI). Type-II MI was defined as MI secondary to ischemia due to either increased oxygen demand or decreased supply caused by conditions as coronary artery spasm, coronary embolism, anemia, arrhythmias, hypertension, or hypotension [1] .In critically ill patients, or in patients undergoing major (non-cardiac) surgery, elevated values of cardiac biomarkers may appear, due to the direct toxic effects of endogenous or exogenous high circulating catecholamine levels. Also coronary vasospasm and/or endothelial dysfunction have the potential to cause MI. Most common causes with respect to frequency are anemia, sepsis, arrhythmia and postoperative status [2] . Numerous pathologies can cause disequilibrium in the balance between oxygen supply and demand. This balance is a critical determinant of the normal cardiac function, and understanding the variables involved is fundamental to understand the ischemic response in Type2 MI. Myocardial oxygen demand relies on three major determinants: systolic wall tension, contractility, and heart rate, whereas myocardial oxygen supply relies on the coronary blood flow and oxygen-carrying capacity. Disequilibrium in the myocardial supply and demand caused by alteration of factors involved in these complex hemodynamic interactions may lead to myocardial ischemia. For example, both hypoxia and anemia can decrease oxygen carrying capacity, leading to an imbalance secondary to supply mismatch.
This may result in ischemia, which, if severe enough, may lead to myocardial cell death with symptoms and/ or ECG changes and release of cTn [3] . If cTn exceeds the 99th percentile and there is a rising and/ or falling 
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